Advances in Hematological Malignancies
Recent centuries have witnessed remarkable advancements in the domain of hematological malignancies. Novel approaches such as targeted drugs, immunotherapies, and gene editing are transforming the prognosis for patients with blood cancers. Clinical trials continue to explore these innovative strategies, offering potential for more successful treatm